Skip to main content

Table 3 Biochemical variables of the ROH-RBP4-TTR complex in plasma of CLD patients classified for individual liver diseases.

From: Isoforms of Retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver

 

Fibrosis1 (n = 38)

HCC2 (n = 10)

Cirrhosis (n = 7)

ROH (μmoL/L)

1.15 (0.87 – 1.40)

0.68 (0.55 – 0.85) *

0.51 (0.38 – 0.72) *

RBP4 (μmoL/L)

0.98 (0.64 – 1.36)

1.02 (0.76 – 1.02)

0.53 (0.41 – 0.82) *

TTR (μmoL/L)

1.44 (1.86 – 3.09)

1.02 (0.91 – 1.26)

1.00 (0.93 – 1.40)

RBP4/ROH ratio 3

0.97 (0.83 – 2.17)

1.53 (1.00 – 2.13)

1.07 (0.97 – 1.26) *

RBP4/TTR ratio 4

0.71(0.38 – 1.13)

1.05 (0.55 – 1.36)

0.51 (0.41 – 0.61) #

RBP4-L (%)5

33.00 (17.00 – 46.00)

31.00 (16.50 – 56.00)

44.00 (20.00 – 58.00)

RBP4-LL (%) 5

0.00 (0.00 – 6.00)

6.00 (0.00 – 8.00)

0.0 (0.0 – 0.0)

  1. Data are expressed as median with 25th and 75th percentiles.
  2. 1 Fibrosis stage 0–4, 2 HCC = Hepato-cellular carcinoma;
  3. 3 The RBP4/ROH ratio is the molar ratio of serum RBP4 to serum ROH.
  4. 4 The RBP4/TTR ratio is the molar ratio of serum RBP4 to serum TTR.
  5. 5 The intensity of the non-truncated RBP4 (nRBP4) was set 100% and intensities of RBP4-L and RBP4-LL were expressed in % of nRBP4.
  6. * = significantly different from Fibrosis patients < (p < 0.05). # = significantly different from HCC patients (p < 0.05).
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X